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Available online 22 May 2012Abstract DNA double-strand breaks (DSBs) in embryonic stem (ES) cells are repaired primarily by homologous recombination
(HR). The mechanism by which HR is regulated in these cells, however, remains enigmatic. To gain insight into such regulatory
mechanisms, we have asked how protein levels of Rad51, a key component of HR, are controlled in mouse ES cells and mouse
embryo fibroblasts (MEFs). The Rad51 protein level is about 15-fold higher in ES cells than in MEFs. The level of Rad51 mRNA,
however, is only ~2-fold higher, indicating that the differences in mRNA levels due to rates of transcription or mRNA stability
are not sufficient to account for the large difference in the abundance of Rad51 protein. Comparison of Rad51 half-lives
between ES cells and MEFs also did not explain the elevated level of Rad51 protein in the ES cells. A comparative assessment
of the Rad51 translation level demonstrated that it is translated with much greater efficacy in ES cells than in MEFs. To
determine whether this high level of translation in ES cells is a general phenomenon in these cells or whether it is a
characteristic of specific proteins, such as those involved with recombination and cell cycle progression, we compared
mechanisms that regulate the level of Pcna in ES cells with those that regulate Rad51. The half-life of Pcna and its rate of
synthesis were considerably different from those of Rad51 in ES cells, demonstrating that regulation of Rad51 abundance
cannot be generalized to other ES cell proteins and not to proteins involved in DNA replication and cell cycle control. Finally,
we show that only a small proportion of the abundant Rad51 protein population is activated under basal conditions in ES cells
and recruited to DNA DSBs and/or stalled replication forks.
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Embryonic stem (ES) cells are derived from cells of the inner
cell mass at the blastocyst stage of embryogenesis and are
capable contributing to the development of the organism
through multiple rounds of division followed by specifically-
timed programmed differentiation. In culture, murine ES
cells can be characterized as having a rapid cell cycle,
125Rad51 regulation in ES cellsdefined by short gap phases with a large proportion of the
cell cycle devoted to S-phase (White and Dalton, 2005). This
observation implies that a majority of gene products
involved in both DNA replication and DNA repair should be
active and readily accessible in these cells. Furthermore,
the promoters of many of the genes involved in DNA
replication contain E2F binding sites, and their expression
is coordinately expressed upon entry into S-phase.
The Rad51 protein is a key player in DNA double-strand
break (DSB) repair by homologous recombination (HR). The
expression level of Rad51 typically varies throughout the cell
cycle, with the lowest expression found in the G1 phase,
increasing throughout S-phase, and peaking in G2/M (Chen et
al., 1997; Flygare et al., 1996; Yamamoto et al., 1996). It is at
these late phases of the cell cycle, mid to late S-phase and G2,
that sister chromatids are optimally available as templates for
homology-mediated repair (Saleh-Gohari and Helleday, 2004).
In unchallenged cells, Rad51 protein exhibits a predominantly
diffuse nuclear staining pattern. However, upon induction of
DNA DSBs, Rad51 relocalizes to distinct foci surrounding the
sites of DSBs, where it is involved in both the search for
homologous sequences to serve as templates for repair as well
as the invasion of these templates to facilitate the repair
process (Sinha and Peterson, 2008; Sung et al., 2003). The
exact mechanism bywhich Rad51 performs this function is still
unresolved.
Proliferating cell nuclear antigen (Pcna) is a homotri-
meric ring protein first identified in proliferating cells (Celis
et al., 1987) and has previously been utilized as a prognostic
indicator of tumor grade (Elias, 1997; Jain et al., 1991;
Mangham et al., 1994). Early studies demonstrated that Pcna
functions during DNA replication, serving as a processivity
factor that tethers DNA polymerases δ and ε to replicating
DNA {reviewed in (Kelman, 1997)}. More recent data suggest
additional roles for Pcna in mismatch and base-excision
repair (Gary et al., 1999; Iyer et al., 2008; Lee and Alani,
2006; Matsumoto, 2001; Muller-Weeks and Caradonna, 1996;
Umar et al., 1996), based on protein interactions with
components of the repair machinery, as well as roles in both
error-free and error-prone lesion bypass {reviewed in
(Moldovan et al., 2007)} and apoptosis (He et al., 2009).
We and others have reported that murine ES cells express
high levels of Rad51 protein compared with mouse embryo
fibroblasts (MEFs), which correlates with the increased
propensity of mouse ES cells to repair DNA DSBs by HR
(Serrano et al., 2011; Tichy et al., 2010). In the current study,
we have assessed the mechanisms by which mouse ES cells
maintain abundant Rad51 levels and compared them with
those utilized by MEFs. To establish whether our findings are
peculiar to Rad51 or whether they can be extended to other ES
cell proteins, particularly those involved in cell cycle
progression, we have investigated the mechanisms that
control the levels of the DNA replication protein Pcna for
comparison. Our data prove that the regulation of Rad51 in ES
cells differs at several levels from that of Pcna, demonstrating
that differential controls exist between cell cycle and HR
protein expression, challenging current dogma. Finally, we
askedwhether the level of Rad51 protein is reflective of a high
load of endogenous DNA damage in ES cells and found that
although DSBs and/or stalled replication forks are present in
unchallenged cells, only a small percentage of total Rad51
localized to these sites.Materials and methods
Cell culture and drug treatments
129/Sv ES cells and primary isogenic MEFs were cultured as
described (Tichy et al., 2010). ES cells were separated from
feeder cells using a standard protocol and harvested
immediately or plated on 0.2% gelatin‐coated plates prior
to use in experiments. MEFs were used between passages 2
and 3 for all experiments. Cells were never more than 60%
confluent at the time of harvest. For protein stability
experiments, cells were treated with 25 μg/mL cyclohexi-
mide (RPI Corp.) and harvested at the indicated time points.
For RNA stability experiments, cells were treated with
10 μg/mL actinomycin D (RPI Corp.) and harvested at
indicated times. To induce DNA DSBs, MEFs and ES cells
were treated with either 2 Gy IR (from a 137Cs source) and
harvested after 1 hr, or treated with either 5 μM etoposide
(A.G. Scientific) or 1 mM hydroxyurea (Sigma) for 2 hr, prior
to harvesting.Western blotting
Whole cell lysates were prepared from 5×106 cells using
RIPA buffer (20 mM Tris, pH 8.0, 150 mM NaCl, 1% Igepal
Ca-630, 1% SDS, 0.5% Sodium deoxycholate), including a
protease inhibitor cocktail (RPI Corp.) prior to the addition
of 2× protein loading buffer (20% glycerol, 120 mM Tris, pH
6.8, 4% SDS, 0.01% bromophenol blue). Lysates were boiled
for 10 min and subjected to SDS-PAGE, with minimum of
30 μg protein extract loaded per lane. Proteins were
transferred to PVDF membranes and blocked with 3% milk-
PBS-T. Antibodies raised against Cdc6 (Invitrogen; DCS180),
Chk1 (Santa Cruz; G-4), Chk1 phospho-S317 (Abcam), Cyclin
A (Santa Cruz; C-19), Cyclin E (Santa Cruz; E-4), Dihydrofo-
late reductase (Dhfr; BD Biosciences; 49), Oct4 (Santa Cruz;
H-134), Pcna (Santa Cruz; PC10), Rad51 (Santa Cruz; H-92),
Rad51 phospho-T309 (Abcam), Thymidylate Synthase (TS;
Invitrogen; TS106), β-actin (Sigma), and γ-H2AX (Millipore;
JBW301) were added and incubated overnight at 4 °C. Blots
were subsequently incubated with the appropriate second-
ary antibodies conjugated with horseradish peroxidase prior
to incubating with ECL reagent and exposure to X-ray film.Cell proliferation assays
Cell proliferation was analyzed using the Click-iT EdU Alexa
Fluor 647 kit (Invitrogen), according to the manufacturer's
instructions with minor modifications. For bivariate analysis
by flow cytometry, MEFs and ES cells were incubated with
20 μM EdU for 30 min prior to processing. DNA was stained
with Cell cycle 405-blue provided with the kit. Data were
collected using a BD LSR II (BD Biosciences) with FACSDiVa
software. Cells were excited with either a 635 nm (for Alexa
Fluor 647) or a 405 nm (for DNA dye) laser. Logarithmic or
linear fluorescence was collected for Alexa Fluor 647 or DNA
dye, respectively, using either a 660/20 or 450/50 band pass
filter. Compensation was not required between the two
dyes. Data were plotted as Alexa Fluor 674 intensity versus
DNA dye intensity.
126 E.D. Tichy et al.Immunofluorescence microscopy
ES cells were seeded on gelatin-coated coverslips in the
absence of feeder cells and allowed to grow for 24 hr. Cells
were irradiated with 2 Gy IR or left untreated and were fixed
1 hr post-irradiation with 1% paraformaldehyde in PBS for
10 min. Cells were processed and stained as described
previously (Serrano et al., 2011) using anti-Rad51 (Santa
Cruz; H-92) and γ-H2AX (Millipore; JBW301) antibodies. DNA
was stained with Draq5 (1/2000 in PBS; Biostatus Ltd.).
Images were taken on a LS-510 confocal microscope (Carl
Zeiss) with accompanying LSM software.
Semi-quantitative PCR
RNA from 5×105 129/Sv ES cells or MEFs was isolated using
Tri-Reagent (Molecular Research Center), according to the
manufacturer's instructions. Complimentary DNA was gener-
ated by reverse transcription using the Superscript III two
step RT-PCR system (Invitrogen), using an oligo-dT primer.
Four-hundred nanograms of resultant cDNA was amplified
for 28–32 cycles using primers directed against: Cdc6 (F 5′‐
TGATCGTGTTGGTGTTGGACGAGA-3′; R 5′‐GCAAACATCCAGCG-
CTTTACGGAT-3′), Cyclin A1 (F 5′‐TGGACAGGTTTCTCTCCTG-
CATGT-3′; R 5′‐TTCAAGAACGGGTCAGCTTCCAGA-3′), Cyclin A2
(F 5′‐TCAGTAAACAGCCTGCCTTCACCA-3′; R 5′‐AAGGATCGCCCT-
CATGCTGGTAGT-3′), Cyclin E (F 5′‐TGTCCAAGTGGGCTATGT-
CAACGA-3′; R 5′‐TGGGCTTGGTCCAGCAAATCCAAG-3′), Dhfr
(F 5′‐TCCGCTCAGGAACGAGTTCAAGTA-3′; R 5′‐TGCCTCCGACT-
ATCCAAACCATGT-3′), Glyceraldehyde-3-phosphate dehydro-
genase (Gapdh-F 5′‐CTCCACTCACGGCAAATTCAA-3′; R 5′‐
GATGACAAGCTTCCCATTCTCG) and Ts (F 5′‐TCCTCTGCTCAC-
AACCAAACGAGT-3′; R 5′ TACAACTGACAGAGGGCATGGCAA-3′).
PCR products were electrophoresed on agarose gels containing
ethidium bromide and visualized under UV light.
Quantitative PCR (qPCR)
QPCR preparation and analysis was performed as described
previously (Tichy et al., 2010). For RNA stability studies, target
gene expression is displayed as the ratio of target/Gapdh,
normalized to MEFs and was carried out in duplicate. Primers
used were: Gapdh (F 5′‐CTCCACTCACGGCAAATTCAA-3′ and R
5′‐GATGACAAGCTTCCCATTCTCG-3′), Pcna (F 5′‐AAAGAAGAG-
GAGGCGGTAACCA-3′ and R 5′‐GGAGACAGTGGAGTGGCTTTTG-




For 35S labeling, cells were incubated in DMEM (lacking
methionine and cysteine; supplemented with 15% dialyzed
fetal bovine serum) for 1 hr to eliminate unlabeled and
unincorporated methionine prior to the addition of 50 μCi/mL
Tran35S Label (comprised of ~70% methionine and 15%
cysteine; MP Biomedicals). Cells were lysed in one of two
buffers for immunoprecipitation. For Rad51 and Pcna, cells
were lysed in 150 mM NaCl, 0.05% SDS, 0.05% Sodium
deoxycholate, and 50 mM Tris, pH 7.5 containing a proteaseinhibitor cocktail (RPI Corp.). For immunoprecipitation of
Gapdh, cells were lysed in 150 mM NaCl, 0.5% Igepal CA-630,
0.1% Brij 35, 0.1% Sodium deoxycholate, and 10 mM Hepes, pH
7.9 containing protease inhibitors. To shear DNA, lysates were
passed through a 26 gauge needle. Debris was removed by
centrifugation at 16,000×g for 1 min. Lysates were incubated
overnight at 4 °C with a polyclonal anti-Rad51 antibody
(Abcam), monoclonal Pcna antibody (Santa Cruz), polyclonal
anti-Gapdh antibody (Abcam), or appropriate normal IgG as a
control. Forty microliters of Protein A/G Plus agarose beads
(Santa Cruz) was added and lysates were incubated for 2 hr at
4 °C. After low-speed centrifugation (850 ×g), the supernatant
was discarded and the pellet washed 4× with IP wash buffer
(160 mMNaCl, 0.1% SDS, 0.05% Sodium deoxycholate, 1% Igepal
Ca-630, 50 mM Tris, pH 7.5) for Rad51 and Pcna, or with Gapdh
lysis buffer for 10 min each at 4 °C. Beads were boiled for
10 min after addition of 2× protein loading buffer and
subjected to SDS-PAGE using 12% polyacrylamide gels. Silver
staining was carried out using a commercially available kit
(Thermo) to gauge the amount of immunoprecipitated protein
loaded onto the gel. Gels were dried and exposed to a
phosphorimager screen. Bands were visualized using the
Storm Phosphorimager (Molecular Dynamics/GE Healthcare)
and quantitated using Imagequant software.
Results
Characterization of Rad51 and DNA replication gene
products in MEFs and ES cells
Several reports demonstrate that many proteins involved in
HR, including the Rad51 protein, are expressed at very high
levels in ES cells when compared with more differentiated
cell types (Serrano et al., 2011; Tichy et al., 2010). This was
confirmed in using isogenic MEFs and ES cells (Fig. 1A). Since
HR, and consequently Rad51, is active predominantly in the
S- and G2-phases of the cell cycle in a majority of cell types,
we probed asynchronous MEF and ES cell populations for
differences in their cell cycle profiles that might account for
the high level of Rad51 in ES cells. To this end, MEFs and ES
cells were pulsed for 30 min with EdU, a thymidine analog,
which is incorporated into DNA during S-phase of the cell
cycle. When cells were analyzed for EdU incorporation using
bivariate flow cytometry, nearly 90% of the ES cells were in
the S- or G2/M-phases of the cell cycle, compared with only
about 50% of MEFs under the same conditions (Fig. 1B),
consistent with the trend of protein expression seen in
Fig. 1A. It should be noted that since 75–80% of passage 3
MEFs incorporate EdU when labeled for 24 hr (Supplementary
Fig. 1); the low abundance of Rad51 protein in MEFs cannot
be attributed to the presence of quiescent or senescent cells
(Trojanek et al., 2003), which typically express low levels of
Rad51 protein (Serrano et al., 2011; Tichy et al., 2010).
Additionally, the high abundance of Rad51 protein in ES cells
is unlikely to be due to contamination of the ES cells with
the mitomycin C‐treated MEF feeder cells (Supplementary
Fig. 2). In fact, ES cells express a higher level of Rad51 in the
absence of feeder cells than when harvested along with the
feeder layer.
We hypothesized that maximal expression of Rad51 in ES
cells may be coordinated with the entry of cells into S-phase,
Figure 1 Characterization of Rad51 and other E2F target gene and protein expression in ES cells and MEFs. A. Western Blot of Rad51
in asynchronous MEFs and ES cells. Oct4 served as a marker of undifferentiated ES cells and β-actin was used as a loading control.
B. Analysis of the cell cycle distribution in asynchronous early-passage MEFs or ES cells. Cells were pulse labeled with 5-ethynyl-2′-
deoxyuridine (EdU), a thymidine analog, for 30 min before processing and analysis by bivariate flow cytometry. The abscissa
represents DNA content by staining with 405-Blue, and the ordinate represents labeling by EdU and Alexa fluorescence. C. Western
blots for indicated proteins involved in DNA replication in MEFs and ES cells. Dhfr—dihydrofolate reductase, Ts—thymidylate synthase.
D and E. RT-PCR using cDNA generated from asynchronous MEFs and ES cells. Amplification was performed using primers for the genes
indicated that are involved in D. DNA replication; or, E. for Rad51.
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replication in other cell types (Bracken et al., 2004; Fujii-
Yamamoto et al., 2005). To test this proposition, we charac-
terized the expression levels of several proteins that regulate
the initiation and progression of DNA replication by western
blotting. As shown in Fig. 1C, Cdc6, Cyclin A, Cyclin E,
Dihydrofolate Reductase (Dhfr), and Thymidylate Synthase
(Ts) all express more robustly in asynchronous ES cells than in
MEFs. The promoters of a majority of genes encoding proteins
that control the entry of cells into S-phase contain E2F binding
sites. Since the Rad51 promoter also contains these elements
(Bracken et al., 2004; Ishida et al., 2001; Lee et al., 1995), we
postulated that the high abundance of Rad51 protein in ES cells
may be regulated in the same manner. Fig. 1D demonstrates a
general trend of increased transcription in ES cells of genes
containing E2F binding sites, consistent with a previous report
(Fujii-Yamamoto et al., 2005). When Rad51 transcripts were
compared between MEFs and ES cells, the ES cells expressed a
higher level of Rad51 message (Fig. 1E), suggesting that Rad51
may be regulated at the transcriptional level.The abundance of Rad51 protein is controlled at
multiple levels in ES cells
To better understand how the high levels of Rad51 protein in
ES cells are controlled and maintained, we first assessed the
extent to which Rad51 protein is overexpressed in ES cells.
There is approximately 15-fold more Rad51 in ES cells than in
MEFs (Fig. 2A). In contrast, quantitative PCR revealed that
Rad51 mRNA is only about 2-fold higher in ES cells (Fig. 2B).
This finding is consistent with the cell cycle data from Fig. 1
and indicates that differences in transcription levels be-
tween the cell types may contribute, but is insufficient, to
explain the Rad51 protein elevation in ES cells.
To determine whether differences in the stability of
Rad51 mRNA might contribute to the high abundance of
Rad51 in ES cells, MEFs and ES cells were treated with
actinomycin D at doses that inhibit transcription mediated
by all RNA polymerases (Sobell, 1985). The kinetics of Rad51
mRNA diminution were assessed over a five-hour time course
and showed no significant differences in Rad51 mRNA decay
Figure 2 Mechanisms for maintaining elevated levels of Rad51 in ES cells. A. Whole cell lysates from MEFs or ES cells were diluted as
indicated with loading buffer or left undiluted prior to completing Western blots for Rad51. β-actin served as a loading control.
B. Analysis of Rad51 transcript levels by qPCR in MEF and ES cells expressed as the ratio of Rad51/Gapdh and normalized to MEFs. Error
bars represent the S.E.M. from at least two independent experiments performed in triplicate. C. MEFs and ES cells were treated with
actinomycin D to inhibit mRNA synthesis and were harvested at the indicated times for qPCR analysis. The data are displayed as the
ratio of Rad51/Gapdh at each time point with data from each cell type normalized to its respective untreated sample. Error bars
represent the S.E.M. from two independent experiments performed in triplicate. D. MEFs (upper panel) or ES cells (lower panel) were
treated with cycloheximide to inhibit new protein synthesis before harvesting at the indicated time points for Western blot analysis
using antibodies to Rad51 or β-actin. Note: 10 times more lysate was used in the MEF lanes due to the low expression of Rad51 in these
cells. E and F. Comparison of relative rates of translation between MEFs and ES cells for Rad51 or Gapdh. Cells were grown in
methionine-free medium prior to labeling with 35S methionine for 1 hr. Cells were lysed, and cell lysates were immunoprecipitated
with antibody before SDS-PAGE. Gels were silver stained to determine protein content prior to autoradiography. A minimum of three
experiments were used for analysis. Error bars represent the S.E.M.
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chosen as it corresponds to about one half of the cell cycle
time of ES cells grown under standard conditions in our
laboratory (Supplementary Fig. 3). The stability of the Rad51
protein in ES cells was also assessed and compared with that
of MEFs following inhibition of translation by cycloheximide
(Schneider-Poetsch et al., 2010). Unexpectedly, the level of
Rad51 in MEFs remained constant over the time course of
treatment while the Rad51 half-life in ES cells is very short,
with no Rad51 observable by 3 hr (Fig. 2D). The short half-
life of Rad51 in ES cells clearly eliminates the stability of the
protein as a factor contributing to the high levels of this
protein in these cells.
The differences in Rad51 protein stability and that of its
RNA between MEFs and ES cells cannot explain the elevated
Rad51 protein level seen in ES cells. Furthermore, the rate
of transcription may only account for about 20% of the 15-
fold protein elevation seen in these cells. Consequently,
translation efficiencies of the Rad51 protein were compared
between the cell types. To this end, cells were grown for
1 hr in medium containing 35S labeled methionine and
cysteine, lysed, and subjected to immunoprecipitation with
either IgG control antibody or Rad51 antibody prior to
separation by SDS-PAGE and autoradiography. Incorporation
of 35S methionine/cysteine into Rad51 was about 6-fold
higher in the ES cells than in MEFs (Fig. 2E). These datasuggest that the high abundance of Rad51 protein in ES cells
compared with MEFs is likely to be a consequence of higher
rates of both transcription and translation. To ask whether
the greater efficiency of Rad51 translation in ES cells
compared with MEFs is generally characteristic of translation
in ES cells, the same approach was used to investigate the
translation rate of glyceraldehyde 3-phosphate dehydroge-
nase (Gapdh). In contrast to Rad51, the translation of Gapdh
was four times more efficient in MEFs than ES cells (Fig. 2F).Expression patterns of Rad51 and Pcna in ES cells
are similar
To determine whether ES cells regulate Rad51 in the same
fashion as other proteins involved in DNA replication or cell
cycle progression, we compared the expression of Rad51
with that of Pcna in ES cells. Both Rad51 and Pcna proteins
were greatly elevated in ES cells compared with MEFs under
basal conditions (Figs. 1A and 3A). Using a series of lysate
dilutions, we determined that the Pcna protein was about
five-fold more abundant in ES cells compared with MEFs
(Fig. 3B). Since the gene encoding Pcna contains E2F binding
sites within its promoter, we expected to see elevated levels
Pcna transcription levels in the ES cells similar to that
observed with Rad51. However, qPCR analysis of Pcna mRNA
Figure 3 Analysis of Pcna and Rad51 expression and regulation in ES cells. A. Western blots for Pcna using MEF and ES whole cell
lysates. Undifferentiated cells were identified using Oct4 as a marker. B. ES whole cell lysate was diluted as indicated or left
undiluted and compared to undiluted MEF lysate for the level of Pcna expression. C. QPCR analysis of Pcna expression in MEFs and ES
cells. Data are displayed as the ratio of Pcna/Gapdh normalized to MEFs. D. ES cells were treated with actinomycin D and harvested at
the indicated time points for qPCR analysis using primers for Rad51 or Pcna. Data are presented as relative mRNA units. E. A
comparison of the stabilities of Pcna and Rad51 proteins in ES cells after treatment with cycloheximide at the indicated time points by
Western blotting. F. Relative rates of translation of Rad51 and Pcna were measured by 35S methionine incorporation over a one‐hour
period in ES cells. Error bars represent the S.E.M.
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ES cells (Fig. 3C), demonstrating that Rad51 and Pcna utilize
different mechanisms for regulating their respective protein
levels.Pcna is a stable protein in ES cells and is translated
with high efficacy
Since differences in the transcript levels are not sufficient to
account for the elevated abundance of Pcna levels found in
ES cells, compared with MEFs, mRNA stability was examined
by treatment of the cells with actinomycin D. Based on
this approach, there were no significant differences Pcna
and Rad51 mRNA levels (Fig. 3D). Unlike Rad51 protein,
however, the Pcna protein level remained stable in ES cells
during the five-hour cycloheximide treatment (Fig. 3E),
consistent with observations in other cell types (Bravo and
Macdonald-Bravo, 1985; Yu et al., 2009). The translation
efficacy of Pcna in ES cells is also very high, displaying a rate
about 7 times higher than that of Rad51 (Fig. 3F). This
difference cannot be attributed to differences in the number
of sulfur-containing amino acids between the two proteins,
as they differ by only one residue. In this respect, these data
demonstrate that ES cells utilize different mechanisms toregulate the levels of proteins involved primarily in DNA
replication versus those with major roles in DNA DSB repair.
ES cells are primed to repair DNA DSBs and/or
restart stalled replication forks
While the elevated expression of Pcna protein in ES cells is
consistent with its role in DNA replication and the large
proportion of the cell cycle devoted to S-phase in these
cells, the requirement, if any, for elevated Rad51 protein is
less clear. To determine if high Rad51 protein is in response
to a large endogenous load of DNA damage in ES cells, we
examined the relative levels of activated Rad51 protein in
unperturbed ES cells and in MEFs as a control cell type.
Phosphorylation of Rad51 on threonine 309 by Chk1 is crucial
to promote Rad51 participation in HR (Sorensen et al.,
2005). As an additional control, cells were treated with very
low doses of several agents that can induce DNA DSBs,
including ionizing radiation (IR), etoposide (ETO), and
hydroxyurea (HU). Both MEFs and ES cells displayed very
low levels of phosphorylated Rad51 protein under basal
conditions (Fig. 4A). Phosphorylated Rad51 levels increased
in both cell types, in response to DNA damage, regardless of
treatment type. There was no significant change, however,
in the total levels of Rad51. Under the same conditions, both
Figure 4 Measurement of Rad51 activation in ES cells. A. ES cells were harvested untreated (UNT) or treated with 2 Gy ionizing radiation
(IR), etoposide (ETO), or hydroxyurea (HU) to induce DNA DSBs. Western blots were conducted using antibodies to the indicated proteins.
MEFs are included as a control, using 10 timesmore lysate than for ES cells. B. ES cells were fixed untreated or 1 hr after treatment with 2 Gy
IR and stainedwith antibodies against Rad51 andγ-H2AX for confocal immunofluorescent analysis. Nuclei were stainedwith DRAQ5. Scale bar
represents 10 μm. Cells in the Rad51light images are the same as those in the Rad51 plane, except laser output was lowered prior to imaging.
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of DNA damage, total Chk1 protein levels increased in both
cell types, but remained low in unchallenged cells. These
data suggest that only a small population of total cellular
Rad51 protein participates in DSB repair in unchallenged ES
cells.
To determine whether Rad51 protein localizes to DNA DSBs
in ES cells, immunofluorescence experiments were performed
in the absence or presence of DNA damage (Fig. 4B). Under
basal conditions, γ-H2AX foci, suggestive of DNA DSBs, were
present in the cells at a low level, and are likely the result of
DSBs induced by endogenous processes. Although Rad51
protein was predominantly distributed diffusely throughout
the nucleus, several discrete foci were detectable under low
intensity laser excitation. A majority of the Rad51 foci loosely
co-localized with γ-H2AX, suggesting that HR was taking place
at these sites. When ES cells were challenged with IR, the
abundance of both Rad51 and γ-H2AX increased, as did their
co-localization. These data suggest that ES cells do not carry a
large burden of endogenous DSBs, but appear to consistently
maintain an excess of Rad51 protein which can rapidly respond
to DSBs as they arise.
In addition to repair of DSBs arising from collapsed
replication forks, another role for Rad51 is the restart ofstalled replication forks prior to their collapse, which is
independent of HR activity (Petermann et al., 2010).
Furthermore, replication fork arrest can also induce H2AX
phosphorylation (Gagou et al., 2010), which may explain the
endogenous γ-H2AX foci observed in ES cells in the absence
of challenge. To identify the contribution of stalled
replication forks that may induce Rad51 foci formation in
ES cells, we have first investigated the expression level of
XRCC3, a protein that can collaborate with Rad51 in
response to DNA DSBs, and is required for replication fork
restart (Petermann et al., 2010). We found higher expression
of XRCC3 protein in the ES cells than in MEFs, similar to
trends observed with Rad51 (Supplementary Fig. 4A). We
then investigated the amount of chromatin-bound Rad51
prior to and after treatment of the cells with thymidine
(Supplemental Fig. 4B), which can promote the slowing and
eventual stalling of replication forks without inducing DNA
DSBs (Lundin et al., 2002) by causing imbalance of nucleotide
pools, and found a small proportion of Rad51 bound to
chromatin in the absence of challenge. The proportion of
chromatin-bound Rad51 increased following thymidine treat-
ment. Thus, the possibility that Rad51 localizes to stalled
replication forks in unchallenged ES cells to promote their
restart cannot be eliminated.
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Rad51 plays a critical role in HR, which is the predominant
pathway of DSB repair in mouse (Serrano et al., 2011; Tichy
et al., 2010) and human (Adams et al., 2010) ES cells. This is
in contrast to somatic cells where NHEJ predominates.
Recently, Serrano et al. (2011) have shown that HR-mediated
repair in murine ES cells is not confined to the S-phase and G2,
but occurs throughout the cell cycle. This finding contrasts
with the conventional dogma for somatic cells which argues
that HR occurs predominantly in late S- and G2-phases of the
mammalian cell cycle when more homologous templates in
the form of sister chromatids are available for recombination.
To better understand how HR repair is controlled in ES cells,
we investigated how the expression of Rad51 is regulated in
mouse ES cells as a preliminary step to determining how HR
may be controlled in these cells. The principal finding was that
the abundance of Rad51 protein in ES cells is controlled by a
combination of selectively elevated transcription and transla-
tion when compared with isogenic MEFs, which were used as
the cell type representing differentiated somatic cells.
Since the Rad51 promoter contains binding sites for the
E2F transcription factor, which is primarily active during
entry of cells into S-phase (Bracken et al., 2004; Dyson,
1998; Shirodkar et al., 1992), one might expect that the
proportion of the cell cycle spent in S-phase might account
in part for the difference in Rad51 transcript levels between
ES cells and MEFs. Indeed, the proportion of ES cells in S-
phase is about twice that of MEFs, which is similar to the
difference in Rad51 mRNA levels between the two cell types.
While the two-fold difference in transcript level is signifi-
cant between MEFs and ES cells, it is not sufficient to explain
the 15-fold difference in protein level between the two cell
types. Additionally, we did not observe any significant
differences of Rad51 protein expression in ES cells through-
out the cell cycle (Supplementary Fig. 3), confirming that
the observed elevation is not merely the product of E2F-
dependent control. When these data are integrated with the
observed increased level of Rad51 translation in the ES cells,
however, the difference in protein levels between MEFs and
ES cells can be reconciled. This observation correlates well
with several studies, which suggest that the abundance of a
majority of cellular proteins is controlled at the level of
translation, and is less dependent on respective protein and
mRNA stabilities using NIH 3T3 cells (Schwanhausser et al.,
2011) or ES cells (Lu et al., 2009).
There are very few additional studies using ES cells that
have systematically measured rates of translation for com-
parative purposes with differentiated cell types. The most
common rationale for studying translation in ES or ES-like cells
is to better identify markers characteristic of the least
differentiated cells, with the aim of enhancing their separa-
tion from unwanted differentiated cells. The typical pro-
tocol utilizes a stepwise approach that is coined translation
state array analysis (TSAA). The strategy includes sorting for
known markers of undifferentiated and differentiated cells
after immunostaining, obtaining microarray data from the
differentially sorted populations, and identifying polysome-
associated mRNAs from those datasets, particularly those
proteins which would be found at the cell surface (Kolle et al.,
2009). In this manner, novel candidates could be identified
that are differentially expressed at the protein level betweenundifferentiated and differentiating ES cells. Recently, using
this approachwhile asking a different question, Sampath et al.
(2008) discovered major differences in the translation of
multiple transcripts between undifferentiated ES cells and ES
cells that were induced to differentiate for 5 days into
embryoid bodies (EBs). Surprisingly, the majority of proteins
profiled were translated at significantly higher levels in the
differentiated EBs than in ES cells, which associated with
increased in mTOR activity. The elevated mTOR activity
resulted in increased phosphorylation of 4E-BP1, an inhibitory
protein that binds the translation initiation factor eIF4E,
which in turn promoted the release of eIF4E and activated
higher levels of translation. The results of this study imply that
ES cells typically translate proteins with lower efficiency than
differentiated cell types, at least at the time point chosen.
Another study by Ingolia et al. (2011) utilized a ribosomal
profiling approach to compare undifferentiated mouse ES
cells and ES cells induced to differentiate and harvested at
different times after induction. During the early stages of
differentiation, their findings were similar to those reported
by Sampath et al., 2008. At later time points of differenti-
ation into EBs, however, translation of ribosomal proteins
was less efficient compared with undifferentiated ES cells,
even though expression of mRNAs encoding those proteins
remained elevated in the EBs. Additionally, these authors
showed that 5′ UTR translation decreased by 25% in the
differentiating EBs compared with the ES cells, demonstrat-
ing that the translational control program changes dramat-
ically during the differentiation process (Ingolia et al.,
2011). When the translation of Rad51 and Pcna was
examined in ES cells before and after LIF withdrawal, there
was a slight downregulation in the production of both of
these proteins in the differentiating ES cells, which the
authors attribute to a downregulation in the abundance of
mRNA transcripts (Ingolia et al., 2011).
In our study, we have observed that both Rad51 and Pcna
are translated at higher efficiencies in ES cells than in MEFs
using a radiolabeled amino acid incorporation approach. This
finding is not necessarily in conflict with previous reports,
since we used terminally differentiated MEFs rather than EBs,
and in MEFs, Gapdh was translated at a higher rate than in ES
cells. Our data imply that there is a select set of proteins that
ES cells preferentially translate with high efficiency, the
majority of which are likely cell cycle regulatory proteins and
proteins involved in DNA repair pathways.
The question remains as to why Rad51 is expressed at
such high levels in the ES cells. Both Rad51 and Chk1 are
phosphorylated in ES cells under basal conditions, but the
level of activated proteins represents only a small fraction of
the protein population (Fig. 3). To validate these findings
and gain better insight into the role of elevated Rad51 in ES
cells, we probed for focus formation in the absence of and
following treatment with agents that damage DNA. Several
Rad51 foci co-localized loosely with γ-H2AX, consistent with
other reports (Banath et al., 2009; Serrano et al., 2011),
suggesting that the Rad51 foci are associated with sites of
DNA DSBs, stalled replication forks, or with a particular
chromatin architecture that induces the phosphorylation of
H2AX. In many cell types, some proteins involved in DNA
damage signaling and repair are expressed at a high level but
remain in an inactive state until they are triggered to respond
to DNA damage (Chaturvedi et al., 1999; Chen and Sanchez,
132 E.D. Tichy et al.2004). Others, such as p53, are induced to high levels by either
an increase in their production and/or a decrease in their
degradation, but only in response to DNA damage (Kubbutat et
al., 1997). The former case may be applicable to Rad51,
particularly in ES cells, since only a portion of the total Rad51
population responds to both endogenous and exogenous DNA
damage by forming foci that co-localize with γ-H2AX. Addi-
tionally, there are no increases in Rad51 protein production
after induction of DNA damage, suggesting that the high level of
Rad51 protein present in ES cells is available for deployment to
sites of DNA DSBs as they arise. There is also a lack of Rad51
protein production in MEFs after treatment with DNA damaging
agents that induce DSBs, at least within the time frame
investigated, indicating that the level of Rad51 protein present
in a cell determines the capacity of that cell to undergo HR.
The rapid cycling times of murine ES cells and the fact that
many of these cells are in S-phase at any given time may
account for the localization of Rad51 foci to DNA DSBs under
basal conditions, perhaps as a consequence of replication
fork slowing/stalling and/or collapse. We cannot eliminate
either of these possibilities as contributing to the level of
Rad51 and γ-H2AX co‐localization, sincewe do see increases in
chromatin-associated Rad51 after chronic treatment of ES
cells with high doses of thymidine, which would create
slowed/stalled replication forks but not induce DNA DSBs
(Supplemental Fig. 4B). Treatment with HU also produces
unbalanced nucleotide pools, promoting replication fork
slowing/stalling, however, induction of DSBs have also been
reported after this treatment (Petermann et al., 2010). While
our treatment of cells with HU was acute and at a low
concentration, we believe, given the rapid cell cycles of ES
cells, that our treatment was sufficient to induce DNA DSBs in
these cells (Fig. 4B). An important point to note is that stalled/
collapsed replication forks should only take place in S-phase of
the cell cycle. While a large proportion of asynchronous ES
cells are in S-phase, there are still approximately 25% of the
cells in other phases of the cell cycle. Serrano et al. (2011) has
shown that DSBs and HR occur throughout the murine ES cell
cycle, proving that Rad51 is not only responding to stalled/
collapsed replication forks to promote their restart.
Endogenous DNA DSBs may also arise as a result of ROS
production derived from oxidative phosphorylation. This
latter possibility is less likely since in ES cells, like in many
cancer cells, glycolysis is the predominant energy production
pathway and oxidative phosphorylation is reduced (Kondoh
et al., 2007). Furthermore, ES cells express antioxidant
proteins at much higher levels than do differentiated cells,
which may ensure that levels of free radicals are kept to a
minimum (Saretzki et al., 2004, 2008).
There are several reports that demonstrate roles for Rad51
in addition to its participation in classical HR-mediated DSB
repair. For example, in Saccharomyces cerevisiae that lack
telomerase or certain telomere binding proteins, the telo-
meres can be maintained in rare survivors by alternative
recombination events dependent on either Rad50 (type II) or
Rad51(type I) (Grandin and Charbonneau, 2003; Le et al.,
1999; Lin et al., 2009). In mammalian cells, an association
between Rad51 and telomeres at the late S and G2 phases of
the cell cycle has been described, and has been proposed to
aid in the formation of the t-loop (Verdun and Karlseder,
2006). Additionally, a recent report has shown that knock-
down of Rad51 protein with shRNA in p53 deficient MEFs or inMEFs with a conditional loss of BRCA2, which is responsible for
loading Rad51 onto DNA, resulted in significant erosion of
telomeres compared with wildtype cells (Badie et al., 2010).
The tight regulation of Rad51 and consequent HR at telomeres,
however, is essential for the prevention of chromosomal
aberrations stemming from telomere sister chromatid ex-
changes that are attributed to inappropriate recombination
(Gauthier et al., 2012). While it is possible that the Rad51 foci
in unchallenged ES cells are associatedwith telomeres, the fact
that many of these Rad51 foci also co‐localize with γ-H2AX
would suggest that the telomeres are damaged, since γ-H2AX is
also used as a marker of uncapped or damaged telomeres (Hao
et al., 2004; Nakamura et al., 2009).
In addition to its roles in telomere maintenance and
replication, Rad51 can physically associate with mitochon-
drial DNA (mtDNA), and in conjunction with other Rad51
family members Rad51C and XRCC3, is critical for maintain-
ing proper mtDNA copy number (Sage et al., 2010).
However, ES cells have few mitochondria per cell (Saretzki
et al., 2008), and all of the detectable Rad51 observed by
immunofluorescence is localized in the nucleus, suggesting
that the predominant role of the elevated Rad51 protein
expression in these cells is to participate in DNA DSB repair
and/or other potential nuclear functions.
In conclusion, murine ES cells regulate the expression of
Rad51 by multiple mechanisms, which are different than
those in differentiated cells. Additionally, high Rad51
protein expression in these cells does not change signifi-
cantly during the cell cycle, nor is it the result of a high level
of endogenous DNA double-strand breaks. The most plausi-
ble hypothesis to explain these observations is that the
excess Rad51 protein produced in ES cells constitutes a
mechanism by which the cells can rapidly respond to DNA
DSBs or slowed/stalled replication forks in a manner that
does not affect the rate of cell proliferation. At the same
time this mechanism would help preserve genomic integrity
by utilizing high fidelity homologous recombination to repair
endogenous DNA lesions resulting from DSBs.
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